- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02289053
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
May 12, 2017 updated by: Philip Schoenfeld, University of Michigan
Conflicting guideline recommendations for screening colonoscopy result due to scant data upon which to develop appropriate recommendations.
No previous study has compared the prevalence of advanced adenomas or adenomas (any size) among 40-49 year old individuals with a first degree relative (FDR) with colorectal cancer (CRC) versus 40-49 year old average risk individuals with no family history of CRC.
The purpose of this study is to determine the prevalence of colon adenomas in 40-49 year old individuals and identify risk factors associated with the presence of advanced adenomas.
This data will provide evidence to determine appropriate colon cancer screening guidelines in 40-49 year old persons with a family history of colon polyps or colorectal cancer.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
1623
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Bethesda, Maryland, United States, 20889
- Walter Reed National Military Medical Center
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
Ann Arbor, Michigan, United States, 48105
- Ann Arbor VA Healthcare System
-
Detroit, Michigan, United States, 48201
- John D. Dingell VA Medical Center
-
Ypsilanti, Michigan, United States, 48197
- Huron Gastro
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Durham VA Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 49 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Participants are recruited from the endoscopy units of the participating study sites prior to their colonoscopy procedure.
Description
Inclusion Criteria:
- 40-49 year old asymptomatic men and women referred for colorectal cancer screening with a family history of CRC in a first degree relative;
- 40-49 year old asymptomatic men and women referred for colorectal cancer screening with a family history of polyps in a first degree relative;
- 40-49 year old men and women without a family history of CRC or polyps in a first degree relative who are referred for colonoscopy to evaluate scant hematochezia characterized as red blood on toilet tissue after wiping or small droplets of blood on stool or in toilet water after evacuating stool, abdominal discomfort or altered bowel habits characterized as constipation or diarrhea.
Exclusion Criteria:
- Personal history of iron deficiency anemia within six months of referral;
- Personal history of iron deficiency without anemia within six months of referral;
- Personal history of (+) FOBT within one year of referral;
- Personal history of previous colonoscopy or barium enema within the past 10 years;
- Personal history of previous flexible sigmoidoscopy in the past 5 years;
- Personal history of adenoma, colorectal cancer, inflammatory bowel disease, HNPCC, or familial adenomatous polyposis (FAP);
- Unintentional weight loss > 10 lbs within the previous six months;
- Individuals with family history of CRC AND scant hematochezia;
- Inability to speak and read English.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Positive Family History
Eligible participants with a family history of colorectal cancer or polyps will be grouped into the "subjects" group.
|
Average Risk Patients
Eligible participants without a family history of colorectal cancer or polyps will be grouped into the "control" group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence of advanced adenomas among 40-49 year old individuals with and without a family history of colorectal cancer
Time Frame: Data analysis will begin September 2014 for a duration of three months.
|
The outcome will be assessed after the completion of patient recruitment at all locations in August 2014.
Advanced adenomas are defined as greater than or equal to 10 mm (1 cm).
The presence of adenomas is determined be reviewing patient medical records and pathology reports.
|
Data analysis will begin September 2014 for a duration of three months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Absolute prevalence of advanced adenomas in 40-49 year olds with a family history of colorectal cancer
Time Frame: Data analysis will begin September 2014 for a duration of three months.
|
The outcome will be assessed after the completion of patient recruitment at all locations in August 2014.
Advanced adenomas are defined as greater than or equal to 10 mm (1 cm).
The presence of adenomas is determined be reviewing patient medical records and pathology reports.
|
Data analysis will begin September 2014 for a duration of three months.
|
Absolute prevalence of advanced adenomas in 40-49 year old individuals with a family history of colorectal polyps
Time Frame: Data analysis will begin September 2014 for a duration of three months.
|
The outcome will be assessed after the completion of patient recruitment at all locations in August 2014.
Advanced adenomas are defined as greater than or equal to 10 mm (1 cm).
The presence of adenomas is determined be reviewing patient medical records and pathology reports.
|
Data analysis will begin September 2014 for a duration of three months.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Risk factors associated with the presence of advanced adenomas
Time Frame: Data analysis will begin September 2014 for a duration of three months.
|
Logistic regression will be used to determine if specific risk factors are associated with the risk of adenomas in 40-49 year old individuals.
Data will be collected from patient surveys and medical records.
|
Data analysis will begin September 2014 for a duration of three months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Philip Schoenfeld, MD, University of Michigan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 1, 2006
Primary Completion (ACTUAL)
June 30, 2014
Study Completion (ACTUAL)
June 30, 2014
Study Registration Dates
First Submitted
February 26, 2014
First Submitted That Met QC Criteria
November 7, 2014
First Posted (ESTIMATE)
November 13, 2014
Study Record Updates
Last Update Posted (ACTUAL)
May 15, 2017
Last Update Submitted That Met QC Criteria
May 12, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Digestive System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Neoplasms by Site
- Neoplasms, Glandular and Epithelial
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Gastrointestinal Diseases
- Colonic Diseases
- Intestinal Diseases
- Pathological Conditions, Anatomical
- Intestinal Neoplasms
- Rectal Diseases
- Intestinal Polyps
- Colorectal Neoplasms
- Adenoma
- Polyps
- Colonic Polyps
- Adenomatous Polyps
Other Study ID Numbers
- K24-DK
- 1K24DK084208 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Cancer
-
University of California, San FranciscoCompletedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRectal Cancer | Colon Cancer | Cancer Survivor | Colorectal Adenocarcinoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingColorectal Adenocarcinoma | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedCancer Survivor | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal Cancer AJCC v8 | Stage IIB Colorectal... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...United States Department of DefenseActive, not recruitingColorectal Adenoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage 0 Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal... and other conditionsUnited States
-
City of Hope Medical CenterRecruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Adenocarcinoma | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Neoplasms Malignant | Colorectal Cancer Stage IUnited States, Japan, Italy, Spain
-
University of Roma La SapienzaCompletedColorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Cancer Stage 0 | Colorectal Cancer Stage IItaly
-
University of Southern CaliforniaNational Cancer Institute (NCI); AmgenTerminatedStage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Colorectal Adenocarcinoma | RAS Wild Type | Stage III Colorectal Cancer AJCC v7 | Stage IIIA Colorectal Cancer AJCC v7 | Stage IIIB Colorectal Cancer AJCC v7 | Stage IIIC Colorectal Cancer...United States